Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

Summary

Sixty advanced breast cancer patients are planed to enrolled in this clinical trial. Forty patients are enrolled into thalidomide plus chemotherapy group. Twenty patients are enrolled into chemotherapy alone group. There is no restriction on chemotherapy regimen and lines.

Timeline

Start

2015-10

Primary completion

2017-06

Completion

2017-10

Drugs

Indications